HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hua Guo Selected Research

Long Noncoding RNA

12/2021Long non-coding RNA AC122108.1 promotes lung adenocarcinoma brain metastasis and progression through the Wnt/β-catenin pathway by directly binding to aldolase A.
8/2021LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
6/2021A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity.
2/2020LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4.
1/2020ZFAS1 Exerts an Oncogenic Role via Suppressing miR-647 in an m6A-Dependent Manner in Cervical Cancer.
1/2018Long noncoding RNA HOXB13-AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma.
4/2017Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway.
12/2016Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.
1/2015Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hua Guo Research Topics

Disease

134Neoplasms (Cancer)
10/2022 - 06/2005
30Breast Neoplasms (Breast Cancer)
04/2022 - 12/2006
29Neoplasm Metastasis (Metastasis)
12/2021 - 04/2009
23Glioma (Gliomas)
02/2022 - 08/2009
22Hepatocellular Carcinoma (Hepatoma)
05/2022 - 01/2013
12Glioblastoma (Glioblastoma Multiforme)
10/2022 - 04/2009
10Lung Neoplasms (Lung Cancer)
09/2021 - 09/2011
9Fibrosis (Cirrhosis)
07/2022 - 08/2003
8Melanoma (Melanoma, Malignant)
12/2021 - 09/2005
8Carcinoma (Carcinomatosis)
07/2021 - 12/2007
8Infections
04/2021 - 01/2014
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 09/2011
7Carcinogenesis
01/2022 - 12/2007
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 01/2013
7Type 2 Diabetes Mellitus (MODY)
01/2020 - 02/2008
6Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 01/2014
6Experimental Melanoma
12/2021 - 01/2006
6Inflammation (Inflammations)
02/2021 - 01/2017
5Asthma (Bronchial Asthma)
03/2022 - 01/2009
5COVID-19
03/2022 - 01/2021
5Pain (Aches)
06/2021 - 11/2016
4Migraine Disorders (Migraine)
01/2022 - 01/2016
4Osteoarthritis
12/2021 - 12/2011
4Hypoxia (Hypoxemia)
09/2021 - 05/2007
4beta-Thalassemia (Cooley's Anemia)
02/2021 - 08/2009
4Hyperglycemia
01/2021 - 01/2019
4Brain Neoplasms (Brain Tumor)
01/2020 - 09/2013
4Major Depressive Disorder (Major Depressive Disorders)
01/2020 - 03/2016
4Insulin Resistance
01/2020 - 10/2014
4Osteoporosis
08/2019 - 03/2012
3Anemia
03/2022 - 12/2009
3Chronic Obstructive Pulmonary Disease (COPD)
03/2022 - 10/2014
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2014
3Adenocarcinoma of Lung
01/2022 - 02/2020
3Pathologic Complete Response
01/2022 - 01/2021
3Weight Loss (Weight Reduction)
11/2021 - 05/2013
3Deafness (Deaf Mutism)
10/2021 - 01/2019
3Shock
02/2021 - 08/2020
3Iron Overload
02/2021 - 06/2011
3Body Weight (Weight, Body)
01/2021 - 05/2013
3Weight Gain
01/2021 - 05/2013
3Sleep Initiation and Maintenance Disorders (Insomnia)
05/2019 - 03/2016
3Lymphatic Metastasis
02/2019 - 12/2006
3Infarction (Infarctions)
12/2017 - 01/2008
3Myocardial Infarction
12/2017 - 01/2015

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
10/2022 - 11/2006
29Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2007
11Biological ProductsIBA
02/2022 - 09/2004
10Pharmaceutical PreparationsIBA
10/2022 - 06/2011
9MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
9Long Noncoding RNAIBA
12/2021 - 01/2015
8Epidermal Growth Factor (EGF)IBA
10/2017 - 05/2002
7IronIBA
03/2022 - 08/2009
7Small Interfering RNA (siRNA)IBA
04/2017 - 04/2009
6Messenger RNA (mRNA)IBA
01/2022 - 04/2009
6ParaffinIBA
01/2021 - 01/2006
6Peptides (Polypeptides)IBA
01/2017 - 10/2008
6Therapeutic UsesIBA
12/2014 - 02/2011
5LigandsIBA
08/2022 - 01/2013
5Oxygen (Dioxygen)IBA
02/2021 - 01/2006
5Cisplatin (Platino)FDA LinkGeneric
02/2021 - 02/2014
5LipidsIBA
01/2020 - 10/2014
5Paclitaxel (Taxol)FDA LinkGeneric
10/2018 - 02/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 03/2012
4AlginatesIBA
04/2022 - 03/2012
4Antidepressive Agents (Antidepressants)IBA
03/2022 - 03/2016
4Hormones (Hormone)IBA
01/2022 - 02/2019
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2005
4RNA (Ribonucleic Acid)IBA
01/2022 - 08/2004
4Interleukin-6 (Interleukin 6)IBA
12/2021 - 04/2016
4CateninsIBA
12/2021 - 12/2016
4EndostatinsIBA
12/2021 - 11/2006
4Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 11/2011
4EnzymesIBA
06/2021 - 12/2011
4NitrogenIBA
02/2021 - 01/2020
4Glucose (Dextrose)FDA LinkGeneric
02/2021 - 02/2008
4Transcription Factors (Transcription Factor)IBA
01/2021 - 02/2012
4cariprazineIBA
01/2019 - 03/2016
4Caspase 3 (Caspase-3)IBA
07/2016 - 12/2011
4Transforming Growth Factor beta (TGF-beta)IBA
12/2014 - 07/2005
4SuspensionsIBA
06/2011 - 01/2006
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2022 - 03/2009
3PPAR alphaIBA
01/2022 - 02/2008
3Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
01/2022 - 01/2021
3AntigensIBA
10/2021 - 08/2008
3Silver Sulfadiazine (SSD)FDA LinkGeneric
10/2021 - 01/2019
3Hemoglobins (Hemoglobin)IBA
01/2021 - 01/2021
3Streptozocin (Streptozotocin)FDA Link
01/2020 - 01/2018
3Phospholipases (Phospholipase)IBA
05/2019 - 01/2017
3Phosphotransferases (Kinase)IBA
01/2019 - 06/2009
3Antipsychotic Agents (Antipsychotics)IBA
01/2019 - 03/2016
3CollagenIBA
01/2018 - 09/2005
3VaccinesIBA
11/2017 - 01/2009

Therapy/Procedure

43Therapeutics
03/2022 - 12/2009
17Drug Therapy (Chemotherapy)
10/2022 - 12/2006
5Transplantation
01/2020 - 05/2002
4Neoadjuvant Therapy
01/2022 - 01/2020
3Immunotherapy
01/2022 - 01/2009
3Conservative Treatment
02/2020 - 05/2013
3Lasers (Laser)
10/2019 - 10/2008